{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:02:11Z","timestamp":1780963331859,"version":"3.54.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":53,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Ministry of Health & Welfare and Ministry of Science and ICT","award":["RS-2024-00335192"],"award-info":[{"award-number":["RS-2024-00335192"]}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2025-00554128"],"award-info":[{"award-number":["RS-2025-00554128"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003716","name":"Korea Basic Science Institute","doi-asserted-by":"publisher","award":["2021R1A6C101A425"],"award-info":[{"award-number":["2021R1A6C101A425"]}],"id":[{"id":"10.13039\/501100003716","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-48974-6","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T02:16:34Z","timestamp":1776392194000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Allyl-substituted ALT001 promotes alternative mitophagy and improves therapeutic outcomes in Alzheimer\u2019s disease models"],"prefix":"10.1038","volume":"16","author":[{"given":"Jee-Hyun","family":"Um","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Myeong","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Yeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Jin","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunhee","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Joo","family":"Maeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alen Benhur Pravin","family":"Nathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihoon","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Hyun","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanho","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"48974_CR1","doi-asserted-by":"publisher","first-page":"e12295","DOI":"10.1002\/trc2.12295","volume":"8","author":"J Cummings","year":"2022","unstructured":"Cummings, J. et al. Alzheimer\u2019s disease drug development pipeline: 2022. Alzheimers Dement. (N Y). 8, e12295 (2022).","journal-title":"Alzheimers Dement. (N Y)"},{"key":"48974_CR2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3389\/fncel.2016.00024","volume":"10","author":"Q Cai","year":"2016","unstructured":"Cai, Q. & Tammineni, P. Alterations in mitochondrial quality control in Alzheimer\u2019s disease. Front. Cell. Neurosci. 10, 24 (2016).","journal-title":"Front. Cell. Neurosci."},{"key":"48974_CR3","doi-asserted-by":"publisher","first-page":"5731","DOI":"10.1038\/s41467-020-19547-6","volume":"11","author":"X Cen","year":"2020","unstructured":"Cen, X. et al. Pharmacological targeting of MCL-1 promotes mitophagy and improves disease pathologies in an Alzheimer\u2019s disease mouse model. Nat. Commun. 11, 5731 (2020).","journal-title":"Nat. Commun."},{"key":"48974_CR4","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13024-020-00376-6","volume":"15","author":"W Wang","year":"2020","unstructured":"Wang, W., Zhao, F., Ma, X., Perry, G. & Zhu, X. Mitochondria dysfunction in the pathogenesis of Alzheimer\u2019s disease: Recent advances. Mol. Neurodegener. 15, 30 (2020).","journal-title":"Mol. Neurodegener"},{"key":"48974_CR5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1750-1326-9-16","volume":"9","author":"L Kukreja","year":"2014","unstructured":"Kukreja, L., Kujoth, G. C., Prolla, T. A., Van Leuven, F. & Vassar, R. Increased mtDNA mutations with aging promotes amyloid accumulation and brain atrophy in the APP\/Ld transgenic mouse model of Alzheimer\u2019s disease. Mol. Neurodegener. 9, 16 (2014).","journal-title":"Mol. Neurodegener"},{"key":"48974_CR6","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1089\/ars.2011.4173","volume":"16","author":"K Leuner","year":"2012","unstructured":"Leuner, K. et al. Mitochondrion-derived reactive oxygen species lead to enhanced amyloid beta formation. Antioxid. Redox Signal. 16, 1421\u20131433 (2012).","journal-title":"Antioxid. Redox Signal."},{"key":"48974_CR7","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.neulet.2009.11.010","volume":"468","author":"B Su","year":"2010","unstructured":"Su, B. et al. Chronic oxidative stress causes increased tau phosphorylation in M17 neuroblastoma cells. Neurosci. Lett. 468, 267\u2013271 (2010).","journal-title":"Neurosci. Lett."},{"issue":"Suppl 2","key":"48974_CR8","doi-asserted-by":"publisher","first-page":"S265","DOI":"10.3233\/JAD-2010-100339","volume":"20","author":"RH Swerdlow","year":"2010","unstructured":"Swerdlow, R. H., Burns, J. M. & Khan, S. M. The Alzheimer\u2019s disease mitochondrial cascade hypothesis. J. Alzheimers Dis. 20 (Suppl 2), S265\u2013279 (2010).","journal-title":"J. Alzheimers Dis."},{"key":"48974_CR9","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.mehy.2003.12.045","volume":"63","author":"RH Swerdlow","year":"2004","unstructured":"Swerdlow, R. H. & Khan, S. M. A mitochondrial cascade hypothesis for sporadic Alzheimer\u2019s disease. Med. Hypotheses. 63, 8\u201320 (2004).","journal-title":"Med. Hypotheses"},{"key":"48974_CR10","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3389\/fnagi.2019.00311","volume":"11","author":"A Chakravorty","year":"2019","unstructured":"Chakravorty, A., Jetto, C. T. & Manjithaya, R. Dysfunctional mitochondria and mitophagy as drivers of Alzheimer\u2019s disease pathogenesis. Front. Aging Neurosci. 11, 311 (2019).","journal-title":"Front. Aging Neurosci."},{"key":"48974_CR11","doi-asserted-by":"publisher","first-page":"e104705","DOI":"10.15252\/embj.2020104705","volume":"40","author":"M Onishi","year":"2021","unstructured":"Onishi, M., Yamano, K., Sato, M., Matsuda, N. & Okamoto, K. Molecular mechanisms and physiological functions of mitophagy. EMBO J. 40, e104705 (2021).","journal-title":"EMBO J."},{"key":"48974_CR12","doi-asserted-by":"publisher","first-page":"299","DOI":"10.5483\/BMBRep.2017.50.6.056","volume":"50","author":"JH Um","year":"2017","unstructured":"Um, J. H. & Yun, J. Emerging role of mitophagy in human diseases and physiology. BMB Rep. 50, 299\u2013307 (2017).","journal-title":"BMB Rep."},{"key":"48974_CR13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.molmed.2019.07.002","volume":"26","author":"G Lou","year":"2020","unstructured":"Lou, G. et al. Mitophagy and neuroprotection. Trends Mol. Med. 26, 8\u201320 (2020).","journal-title":"Trends Mol. Med."},{"key":"48974_CR14","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/s41556-018-0176-2","volume":"20","author":"K Palikaras","year":"2018","unstructured":"Palikaras, K., Lionaki, E. & Tavernarakis, N. Mechanisms of mitophagy in cellular homeostasis, physiology and pathology. Nat. Cell. Biol. 20, 1013\u20131022 (2018).","journal-title":"Nat. Cell. Biol."},{"key":"48974_CR15","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41593-018-0332-9","volume":"22","author":"EF Fang","year":"2019","unstructured":"Fang, E. F. et al. Mitophagy inhibits amyloid-beta and tau pathology and reverses cognitive deficits in models of Alzheimer\u2019s disease. Nat. Neurosci. 22, 401\u2013412 (2019).","journal-title":"Nat. Neurosci."},{"key":"48974_CR16","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41551-021-00819-5","volume":"6","author":"C Xie","year":"2022","unstructured":"Xie, C. et al. Amelioration of Alzheimer\u2019s disease pathology by mitophagy inducers identified via machine learning and a cross-species workflow. Nat. Biomed. Eng. 6, 76\u201393 (2022).","journal-title":"Nat. Biomed. Eng."},{"key":"48974_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.5734\/JGM.2022.19.2.49","volume":"19","author":"KM Lee","year":"2022","unstructured":"Lee, K. M. & Yun, J. Mitophagy stimulation as a novel strategy for the treatment of mitochondrial diseases. J. Genetic Med. 19, 49\u201356 (2022).","journal-title":"J. Genetic Med."},{"key":"48974_CR18","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.jmb.2019.06.032","volume":"432","author":"L Montava-Garriga","year":"2020","unstructured":"Montava-Garriga, L. & Ganley, I. G. Outstanding questions in mitophagy: What we do and do not know. J. Mol. Biol. 432, 206\u2013230 (2020).","journal-title":"J. Mol. Biol."},{"key":"48974_CR19","doi-asserted-by":"publisher","first-page":"56","DOI":"10.7150\/thno.88718","volume":"14","author":"JH Um","year":"2024","unstructured":"Um, J. H. et al. Selective induction of Rab9-dependent alternative mitophagy using a synthetic derivative of isoquinoline alleviates mitochondrial dysfunction and cognitive deficits in Alzheimer\u2019s disease models. Theranostics 14, 56\u201374 (2024).","journal-title":"Theranostics"},{"key":"48974_CR20","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1111\/j.1476-5381.2010.01127.x","volume":"162","author":"JP Hughes","year":"2011","unstructured":"Hughes, J. P., Rees, S., Kalindjian, S. B. & Philpott, K. L. Principles of early drug discovery. Br. J. Pharmacol. 162, 1239\u20131249 (2011).","journal-title":"Br. J. Pharmacol."},{"key":"48974_CR21","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.drudis.2018.01.010","volume":"23","author":"S Mignani","year":"2018","unstructured":"Mignani, S. et al. Present drug-likeness filters in medicinal chemistry during the hit and lead optimization process: How far can they be simplified? Drug Discov. Today. 23, 605\u2013615 (2018).","journal-title":"Drug Discov Today"},{"key":"48974_CR22","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.ejmech.2017.01.012","volume":"127","author":"J Wang","year":"2017","unstructured":"Wang, J. et al. The synthesis and antistaphylococcal activity of 9, 13-disubstituted berberine derivatives. Eur. J. Med. Chem. 127, 424\u2013433 (2017).","journal-title":"Eur. J. Med. Chem."},{"key":"48974_CR23","doi-asserted-by":"crossref","unstructured":"Um, J. H., Kim, Y. Y., Finkel, T. & Yun, J. Sensitive measurement of mitophagy by flow cytometry using the pH-dependent fluorescent reporter mt-Keima. J Vis. Exp (2018).","DOI":"10.3791\/58099-v"},{"key":"48974_CR24","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/nchembio.2287","volume":"13","author":"ND Georgakopoulos","year":"2017","unstructured":"Georgakopoulos, N. D., Wells, G. & Campanella, M. The pharmacological regulation of cellular mitophagy. Nat. Chem. Biol. 13, 136\u2013146 (2017).","journal-title":"Nat. Chem. Biol."},{"key":"48974_CR25","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.bmcl.2008.11.088","volume":"19","author":"GE Lee","year":"2009","unstructured":"Lee, G. E. et al. Synthesis and structure-activity relationships of novel, substituted 5,6-dihydrodibenzo[a,g]quinolizinium P2X7 antagonists. Bioorg. Med. Chem. Lett. 19, 954\u2013958 (2009).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"48974_CR26","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.molcel.2015.10.009","volume":"60","author":"N Sun","year":"2015","unstructured":"Sun, N. et al. Measuring In Vivo Mitophagy. Mol. Cell. 60, 685\u2013696 (2015).","journal-title":"Mol. Cell."},{"key":"48974_CR27","doi-asserted-by":"publisher","first-page":"9742","DOI":"10.1096\/fj.201900073R","volume":"33","author":"YY Kim","year":"2019","unstructured":"Kim, Y. Y. et al. Assessment of mitophagy in mt-Keima Drosophila revealed an essential role of the PINK1-Parkin pathway in mitophagy induction in vivo. FASEB J. 33, 9742\u20139751 (2019).","journal-title":"FASEB J."},{"key":"48974_CR28","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1096\/fj.201901747RR","volume":"34","author":"YY Kim","year":"2020","unstructured":"Kim, Y. Y. et al. p53 regulates mitochondrial dynamics by inhibiting Drp1 translocation into mitochondria during cellular senescence. FASEB J. 34, 2451\u20132464 (2020).","journal-title":"FASEB J."},{"key":"48974_CR29","doi-asserted-by":"publisher","first-page":"4012","DOI":"10.1111\/bph.16476","volume":"181","author":"S Im","year":"2024","unstructured":"Im, S. et al. A novel marine-derived mitophagy inducer ameliorates mitochondrial dysfunction and thermal hypersensitivity in paclitaxel-induced peripheral neuropathy. Br. J. Pharmacol. 181, 4012\u20134027 (2024).","journal-title":"Br. J. Pharmacol."},{"key":"48974_CR30","doi-asserted-by":"publisher","first-page":"3330","DOI":"10.1021\/acs.molpharmaceut.4c00068","volume":"21","author":"M Cha","year":"2024","unstructured":"Cha, M. et al. Chemically driven clearance of amyloid aggregates by polyfunctionalized furo[2,3-b:4,5-b\u2019]dipyridine-chalcone hybrids to ameliorate memory in an Alzheimer mouse model. Mol. Pharm. 21, 3330\u20133342 (2024).","journal-title":"Mol. Pharm."},{"key":"48974_CR31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/361031a0","volume":"361","author":"TV Bliss","year":"1993","unstructured":"Bliss, T. V. & Collingridge, G. L. A synaptic model of memory: Long-term potentiation in the hippocampus. Nature 361, 31\u201339 (1993).","journal-title":"Nature"},{"key":"48974_CR32","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nn.2785","volume":"14","author":"J Jo","year":"2011","unstructured":"Jo, J. et al. Abeta(1\u201342) inhibition of LTP is mediated by a signaling pathway involving caspase-3, Akt1 and GSK-3beta. Nat. Neurosci. 14, 545\u2013547 (2011).","journal-title":"Nat. Neurosci."},{"key":"48974_CR33","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1007\/s11064-014-1343-x","volume":"39","author":"DM Wang","year":"2014","unstructured":"Wang, D. M. et al. Effects of long-term treatment with quercetin on cognition and mitochondrial function in a mouse model of Alzheimer\u2019s disease. Neurochem Res. 39, 1533\u20131543 (2014).","journal-title":"Neurochem Res."},{"key":"48974_CR34","doi-asserted-by":"publisher","first-page":"14670","DOI":"10.1073\/pnas.0903563106","volume":"106","author":"J Yao","year":"2009","unstructured":"Yao, J. et al. Mitochondrial bioenergetic deficit precedes Alzheimer\u2019s pathology in female mouse model of Alzheimer\u2019s disease. Proc. Natl. Acad. Sci. U S A. 106, 14670\u201314675 (2009).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"48974_CR35","doi-asserted-by":"publisher","first-page":"R170","DOI":"10.1016\/j.cub.2018.01.004","volume":"28","author":"S Pickles","year":"2018","unstructured":"Pickles, S., Vigie, P. & Youle, R. J. Mitophagy and quality control mechanisms in mitochondrial maintenance. Curr. Biol. 28, R170\u2013R185 (2018).","journal-title":"Curr. Biol."},{"key":"48974_CR36","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1080\/15548627.2015.1023047","volume":"11","author":"Y Hirota","year":"2015","unstructured":"Hirota, Y. et al. Mitophagy is primarily due to alternative autophagy and requires the MAPK1 and MAPK14 signaling pathways. Autophagy 11, 332\u2013343 (2015).","journal-title":"Autophagy"},{"key":"48974_CR37","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1172\/JCI122035","volume":"129","author":"T Saito","year":"2019","unstructured":"Saito, T. et al. An alternative mitophagy pathway mediated by Rab9 protects the heart against ischemia. J. Clin. Invest. 129, 802\u2013819 (2019).","journal-title":"J. Clin. Invest."},{"key":"48974_CR38","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.bbamcr.2010.08.007","volume":"1813","author":"E Deas","year":"2011","unstructured":"Deas, E., Wood, N. W. & Plun-Favreau, H. Mitophagy and Parkinson\u2019s disease: The PINK1-Parkin link. Biochim. Biophys. Acta. 1813, 623\u2013633 (2011).","journal-title":"Biochim. Biophys. Acta"},{"key":"48974_CR39","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3389\/fneur.2017.00527","volume":"8","author":"F Gao","year":"2017","unstructured":"Gao, F. et al. Mitophagy in Parkinson\u2019s disease: Pathogenic and therapeutic implications. Front. Neurol. 8, 527 (2017).","journal-title":"Front. Neurol."},{"key":"48974_CR40","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.stem.2016.08.002","volume":"19","author":"CH Hsieh","year":"2016","unstructured":"Hsieh, C. H. et al. Functional impairment in miro degradation and mitophagy is a shared feature in familial and sporadic Parkinson\u2019s disease. Cell. Stem Cell. 19, 709\u2013724 (2016).","journal-title":"Cell. Stem Cell."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48974-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48974-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48974-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T23:40:30Z","timestamp":1780962030000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48974-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["48974"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-48974-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"9 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"J.-H. Um, S. Choi, J. Jo, J. H. Cho, and J. Yun have filed a patent about the treatment of AD using a mitophagy inducer. E. Yoo, J. H. Cho, and J. Yun are co-founders of Altmedical co. The other authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17784"}}